Pregabalin concentrations in post-mortem blood-A two year study

Forensic Science International

Volumn 266, Issue , 2016, Pages 197-201

  Eastwood, Jane A ^a   Davison, Elizabeth ^a  

^a LGC   (United Kingdom)

Author keywords

Blood drug concentration; Fatal poisoning; Post mortem; Pregabalin; Therapeutic

Indexed keywords

PREGABALIN;

ADULT; ARTICLE; AUTOPSY; BLOOD SAMPLING; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; SUBSTANCE ABUSE; YOUNG ADULT; BLOOD; DRUG DEPENDENCE; FORENSIC TOXICOLOGY;

FORENSIC TOXICOLOGY; HUMANS; PREGABALIN; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 84973470337     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2016.05.033     Document Type: Article

References (17)

1. British National Formulary, 68 (2014-2015).
2. Brodie M.J., Wilson E.A., Wesche D.L., Alvey C.W., Randinitis E.J., Posvar E.L., Hounslow N.J., Bron N.J., Gibson G.L., Bockcrader H.N. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine and valproate in patients with partial epilepsy. Epilepsia 2005, 46:1407-1413.
3. Baxter K. Stockley's Drug Interactions 2013, 563. 10th ed.
4. May T.W., Rambeck B., Neb R., Jürgens U. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age and comedication. Ther. Drug Monit. 2007, 29:789-794.
5. Gajraj N.M. Pregabalin: its pharmacology and use in pain management. Anesth. Analg. 2007, 105:1805-1815.
6. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2014, 1686-1687. 10th ed.
7. Lottner-Nau S., Obgüer B., Paul L.D., Graw M., Sachs H., Roider G. Abuse of pregabalin-results of the post-mortem toxicology from 2010 to 2012. Toxichem. Krimtech. 2013, 80:339-342.
8. Häkkinen M., Vuori E., Kalso E., Gergov M., Ojanperä I. Profiles of pregabalin and gabapentin abuse in post-mortem toxicology. Forensic Sci. Int. 2014, 241:1-6.
9. Schifano F., Offizi S., Piccione M., Corazza O., Deluca P., Davey Z., et al. Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother. Psychosom. 2011, 80(2):118-122.
10. Grosshans M., Mutschler J., Hermann D., Klein O., Dressing H., Kiefer F., et al. Pregabalin abuse, dependence, and withdrawal: a case report [letter]. Am. J. Psychiatry 2010, 167(July (7)):869.
11. Priez-Barallon C., Carlier J., Boyer B., Benslima M., Fanton L., Mazoyer C., Gaillard Y. Quantification of pregabalin using hydrophilic interaction HPLC-high-resolution MS in postmortem human samples: eighteen case reports. J. Anal. Tox. 2014, 38:143-148.
12. Kriikku P., Wilhelm L., Rintatalo J., Hurme J., Krakmer J., Ojanperä I. Pregabalin serum levels in apprehended drivers. Forensic Sci. Int. 2014, 243:112-116.
13. Song H.K. Serotonin syndrome with perioperative oxycodone and pregabalin. Pain Phys. 2013, 16:E632-E633.
14. Berry D., Millington C. Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC. Ther. Drug Monit. 2005, 27:451.
15. Arroyo S., Anhut H., Kugler A.R., Lee C.M., Knapp L.E., Garofalo E.A., Messmer S. the Pregabalin 1008-011 International Study Group, Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 2004, 45:20-27.
16. Button J., Berry D., Holt D.W. Two fatalities involving pregabalin. Toxichem. Krimtech. 2010, 77:247-248.
17. Adapted from Adler, et al. Overcoming challenges in development of LC/MS/MS methods for highly polar, low molecular weight, zwitterionic compounds. A quantitative assay for pregabalin. Tandem Labs Publ. 2007.